Search

everythinglearnresearchcommunity

for

Search:↓

EPC-CM can reduce skin aging signs by boosting the skin's defense system.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Hair loss caused by genetics and hormones; more research needed for treatments.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Advanced hydrogel systems with therapeutic agents could greatly improve acute and chronic wound treatment.

Electrical stimulation with a low-calorie diet reduces appetite, weight, and blood pressure in obese people with sleep apnea.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Blocking BACE1 and BACE2 enzymes causes hair color loss in mice.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.

Fat cells are important for tissue repair and stem cell support in various body parts.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Early diagnosis and treatment of TPP can prevent complications.

Disruptions in epidermal polarity genes can lead to skin diseases.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Three specific proteins can turn adult skin cells into hair-growing cells, suggesting a new hair loss treatment.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Rat dermal papilla cells have unique genes crucial for hair growth.

The PP2A-B55α protein is essential for brain and skin development in embryos.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.